OG217SC (NN9924)

:Type 2 diabetes
:Phase 2

A long-acting oral GLP-1 analogue intended as a tablet treatment.

Company announcements
No company announcements matching the search criteria

Press releases
Novo Nordisk starts phase 1 trial with long-acting oral GLP-1 analogue (13 Jan 2010)
Read more press releases

Scientific abstracts

No scientific abstracts matching the search criteria

You can search for more clinical trials on http://clinicaltrials.gov